1079 related articles for article (PubMed ID: 8542596)
1. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
2. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.
Forsyth PA; Wong H; Laing TD; Rewcastle NB; Morris DG; Muzik H; Leco KJ; Johnston RN; Brasher PM; Sutherland G; Edwards DR
Br J Cancer; 1999 Apr; 79(11-12):1828-35. PubMed ID: 10206300
[TBL] [Abstract][Full Text] [Related]
3. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y
Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400
[TBL] [Abstract][Full Text] [Related]
4. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.
Velasco G; Cal S; Merlos-Suárez A; Ferrando AA; Alvarez S; Nakano A; Arribas J; López-Otín C
Cancer Res; 2000 Feb; 60(4):877-82. PubMed ID: 10706098
[TBL] [Abstract][Full Text] [Related]
5. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
7. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation.
Benyon RC; Hovell CJ; Da Gaça M; Jones EH; Iredale JP; Arthur MJ
Hepatology; 1999 Oct; 30(4):977-86. PubMed ID: 10498650
[TBL] [Abstract][Full Text] [Related]
8. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
[TBL] [Abstract][Full Text] [Related]
9. Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas.
Groft LL; Muzik H; Rewcastle NB; Johnston RN; Knäuper V; Lafleur MA; Forsyth PA; Edwards DR
Br J Cancer; 2001 Jul; 85(1):55-63. PubMed ID: 11437402
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma.
Qin H; Moellinger JD; Wells A; Windsor LJ; Sun Y; Benveniste EN
J Immunol; 1998 Dec; 161(12):6664-73. PubMed ID: 9862695
[TBL] [Abstract][Full Text] [Related]
11. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors.
Llano E; Pendás AM; Freije JP; Nakano A; Knäuper V; Murphy G; López-Otin C
Cancer Res; 1999 Jun; 59(11):2570-6. PubMed ID: 10363975
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation mediates ConA-induced membrane type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in MDA-MB-231 human breast carcinoma cells.
Yu M; Bowden ET; Sitlani J; Sato H; Seiki M; Mueller SC; Thompson EW
Cancer Res; 1997 Nov; 57(22):5028-32. PubMed ID: 9371497
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors.
Lampert K; Machein U; Machein MR; Conca W; Peter HH; Volk B
Am J Pathol; 1998 Aug; 153(2):429-37. PubMed ID: 9708803
[TBL] [Abstract][Full Text] [Related]
15. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins.
Nakada M; Miyamori H; Yamashita J; Sato H
Cancer Res; 2003 Jun; 63(12):3364-9. PubMed ID: 12810672
[TBL] [Abstract][Full Text] [Related]
16. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
[TBL] [Abstract][Full Text] [Related]
17. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells.
Yu M; Sato H; Seiki M; Thompson EW
Cancer Res; 1995 Aug; 55(15):3272-7. PubMed ID: 7614461
[TBL] [Abstract][Full Text] [Related]
18. Progesterone differentially regulates the membrane-type matrix metalloproteinase-1 (MT1 -MMP) compartment of proMMP-2 activation in MG-63 cells.
Luo XH; Liao EY
Horm Metab Res; 2001 Jul; 33(7):383-8. PubMed ID: 11507673
[TBL] [Abstract][Full Text] [Related]
19. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.
Sato H; Okada Y; Seiki M
Thromb Haemost; 1997 Jul; 78(1):497-500. PubMed ID: 9198203
[TBL] [Abstract][Full Text] [Related]
20. Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes.
Nakada M; Yamada A; Takino T; Miyamori H; Takahashi T; Yamashita J; Sato H
Cancer Res; 2001 Dec; 61(24):8896-902. PubMed ID: 11751414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]